Humana Inc. is a health and well-being company. The Company's segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products. The Group segment consists of employer group commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and voluntary insurance benefits, as well as administrative services only products. The Healthcare Services segment includes services, such as pharmacy solutions, provider services, home-based services and clinical programs, as well as services and capabilities to advance population health. The Other Businesses segment includes its closed-block long-term care insurance policies.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Health Care Plans
- Sub-Industry: Managed Health Care
- Exchange: NYSE
- Symbol: HUM
- CUSIP: 44485910
- Previous Close: $207.28
- 50 Day Moving Average: $202.79
- 200 Day Moving Average: $190.17
- 52-Week Range: $150.00 - $217.80
- Trailing P/E Ratio: 50.93
- Foreward P/E Ratio: 17.40
- P/E Growth: 1.39
- Market Cap: $30.95B
- Outstanding Shares: 149,305,000
- Beta: 0.91
- Net Margins: 1.09%
- Return on Equity: 13.09%
- Return on Assets: 5.21%
Companies Related to Humana:
- Debt-to-Equity Ratio: 0.35%
- Current Ratio: 2.07%
- Quick Ratio: 1.66%
What is Humana's stock symbol?
Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."
How often does Humana pay dividends? What is the dividend yield for Humana?
Humana announced a quarterly dividend on Wednesday, February 15th. Shareholders of record on Friday, March 31st will be given a dividend of $0.40 per share on Friday, April 28th. This represents a $1.60 dividend on an annualized basis and a yield of 0.77%. The ex-dividend date of this dividend is Wednesday, March 29th. This is a boost from Humana's previous quarterly dividend of $0.29.
Where is Humana's stock going? Where will Humana's stock price be in 2017?
17 equities research analysts have issued 1 year target prices for Humana's stock. Their forecasts range from $170.00 to $237.00. On average, they anticipate Humana's share price to reach $208.07 in the next year.
When will Humana announce their earnings?
Humana is scheduled to release their next quarterly earnings announcement on Tuesday, May, 2nd 2017.
What are analysts saying about Humana stock?
Here are some recent quotes from research analysts about Humana stock:
- Cantor Fitzgerald analysts commented, "We are transferring coverage of Humana (HUM) and rate the shares at Neutral; our 12-month DCF-based price target is $186. The shares trade 6% above our price target, probably due in part to continued speculation that HUM remains a takeover candidate. We believe there is a low probability that AET will successfully appeal a recent court decision which ruled against the merger (if it even decides to appeal the decision). We assign a low probability that HUM will be acquired, at least in the short term. HUM's losses relating to the Affordable Care Act will shrink in 2017 and 2018. Medicare continues to perform well, recognizing that HUM 2018 MA reimbursement could be impacted by a reduction in its star ratings. With about 6% downside to our target price, our rating is Neutral." (2/6/2017)
According to Zacks Investment Research, "Humana’s accretive acquisitions, efficient capital deployment, business diversification initiatives and consistent revenue growth paved the way for long term growth. It raised its financial guidance for full-year 2016 on solid performances in Individual Medicare Advantage and Healthcare Services businesses. Strong balance sheet is another positive. Nevertheless over the last one year, the stock has gained 25% lower than 32% gained by the Zacks categorized HMO industry. Increased competition, weakness in individual commercial business, higher expenses, and softness in its group Medicare Advantage business threaten. Moreover, the pending merger with Aetna that would have enhanced Humana’s market power now remains shrouded in uncertainty. The company is set to report its fourth quarter results on Feb 8. A Zacks Rank #3 combined with a negative Earnings ESP of 0.94% makes the earnings prediction uncertain." (1/17/2017)
Stifel Nicolaus analysts commented, "Earlier this week, TBRA announced Ph 2a ORION POC trial interim results of lead." (5/5/2016)
Who owns Humana stock?
Humana's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Glenview Capital Management LLC (4.23%), State Street Corp (4.15%), JPMorgan Chase & Co (3.90%), FMR LLC (2.15%), Dimensional Fund Advisors LP (1.07%) and Renaissance Technologies LLC (0.98%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Cynthia H Zipperle, David A Jr/Ky Jones, James E Murray, Jody L Bilney, M Todoroff Christopher and Roy A Beveridge.
Who sold Humana stock? Who is selling Humana stock?
Humana's stock was sold by a variety of institutional investors in the last quarter, including Janus Capital Management LLC, Tudor Investment Corp Et Al, NN Investment Partners Holdings N.V., GABELLI & Co INVESTMENT ADVISERS INC., CNH Partners LLC, Halcyon Management Partners LP, Taconic Capital Advisors LP and Quinn Opportunity Partners LLC. Company insiders that have sold Humana stock in the last year include Brian P Leclaire, Bruce D Broussard, Cynthia H Zipperle, David A Jr/Ky Jones, James E Murray, Jody L Bilney, M Todoroff Christopher and Roy A Beveridge.
Who bought Humana stock? Who is buying Humana stock?
Humana's stock was purchased by a variety of institutional investors in the last quarter, including Glenview Capital Management LLC, FMR LLC, Renaissance Technologies LLC, Putnam Investments LLC, Marshall Wace LLP, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main, Fred Alger Management Inc. and State Street Corp.
How do I buy Humana stock?
Shares of Humana can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Humana stock cost?
One share of Humana stock can currently be purchased for approximately $207.28.